On Monday, The Lancet medical journal published a paper on trials at UCLA in which hESC-derived cells were transplanted into human patients, with positive results for sufferers of macular degeneration. Parallel trials are currently taking place in the UK at Moorfields Eye Hospital in London. 

The UCLA results have received extensive coverage from CBS News, Reuters, and Time Magazine as well as the UK's Telegraph and Independent.

Macular degeneration is also a target of SENS Foundation research.

Proceed to the article at The Lancet.